• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·2689.T
Share

OLBA HEALTHCARE HOLDINGS, Inc. Stocks

¥ 1908Last Updated 24.07.2026

Issuer Rating

5/7
Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

¥ 70.29M

¥ 1908
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

OLBA HEALTHCARE HOLDINGS, Inc., founded in 1921 and based in Okayama, Japan, provides an extensive range of healthcare and life science solutions to a diverse clientele across the country. Its customers include medical facilities, academic institutions, corporate research laboratories, individuals, and elderly care providers. The company's operations span several key areas. Its Medical Equipment business acts as a wholesale distributor for a wide array of advanced medical devices. This includes prosthetic and implantable items such as artificial joints, pacemakers, and coronary stents; surgical tools like steel instruments and ultrasonic scalpels; and diagnostic imaging systems such, as MRI and CT scanners. Additionally, they supply essential hospital equipment, including respirators, intraoperative monitors, and surgical lighting. In the realm of life sciences, OLBA HEALTHCARE offers specialized reagents and apparatus for genetic research, cell culture, and protein analysis. They also provide automated analyzers for biochemistry, immunology, and blood diagnostics, along with various testing reagents. Furthermore, the company performs dedicated DNA analysis services. The Supply Processing and Distribution (SPD) business supports clients by managing inventory, information, and procurement functions efficiently. Finally, the Nursing Care Products business focuses on enhancing the well-being of those requiring care. This segment offers rental services for nursing care equipment and sells welfare aids such as portable toilets and bathing solutions. They are also involved in managing a program designed to facilitate comfortable long-term care at home, referred to as "long-term care reform." The company rebranded from Kawanishi Holdings, Inc. to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.07.2026 21:33

Revolut Valued at $115 Billion and a Record-Breaking Deal in Asia: Key Takeaways on IPOs as of July 26

26.07.2026 15:01

AI Tools to Combat Cognitive Biases: How Investors Can Use Them

25.07.2026 16:01

Small caps last week: New Nasdaq rules, AI hurting Tripadvisor, Archer's rotorcraft

25.07.2026 13:50

Chevron Discussed with the U.S. How to Protect Its Interests in Kazakhstan from the Effects of the War — WSJ

25.07.2026 13:01

The "Three Seas" Risk Zone, Tesla Hit by Expenses, and "Odyssey" — the Driving Force Behind Movie Theaters

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026